ClinicalTrials.gov
public full text
Public Domain
A Phase II Study of UCN-01 in Metastatic Melanoma
UCN-01 may stop the growth of tumor cells by blocking the enzymes necessary for their growth. This phase II trial is studying how well UCN-01 works in treating patients with metastatic melanoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of GC101 TIL in Advanced Melanoma#837713
- L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma#261496
- Harnessing Proteogenomics to Advance Precision Oncology: From Melanoma and Hepatocellular Carcinoma Perspective.#4330
- DNA Strand Breaks by Small Molecules: From Genomic Hazard to Therapeutic Strategy#291067
- Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis#1153084
Record · ID 1094427
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive